Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn’s Disease
- Resource Type
- Short Survey
- Source
- In
Clinical Gastroenterology and Hepatology March 2023 21(3):838-840 - Subject
- Language
- ISSN
- 1542-3565